{"title":"IGF-1 shown to be a potential novel biomarker to predict type 1 diabetes","authors":"","doi":"10.1002/doi2.00004","DOIUrl":null,"url":null,"abstract":"<p>A recent study published in Nature investigated total serum IGF1, IGF2, and IGFBP1–7 levels were measured in an age-matched, cross-sectional cohort at varying stages of progression to type 1 diabetes showed that the levels and biovailability of Insulin-like growth factors (IGFs), are reduced during type 1 diabetes development. In the study. Further, IGF1 levels decreased over time in subjects with multiple auto Antibodies and those who progressed to type 1 diabetes, particularly post-diagnosis. This study therefore showed IGFs are dysregulated both before and after the clinical diagnosis of type 1 diabetes and may be used as novel biomarkers predict type 1 diabetes in the future.</p><p>URL: https://www.nature.com/articles/s41574-020-0317-0</p>","PeriodicalId":100370,"journal":{"name":"Diabetes, Obesity and Metabolism Now","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/doi2.00004","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity and Metabolism Now","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/doi2.00004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A recent study published in Nature investigated total serum IGF1, IGF2, and IGFBP1–7 levels were measured in an age-matched, cross-sectional cohort at varying stages of progression to type 1 diabetes showed that the levels and biovailability of Insulin-like growth factors (IGFs), are reduced during type 1 diabetes development. In the study. Further, IGF1 levels decreased over time in subjects with multiple auto Antibodies and those who progressed to type 1 diabetes, particularly post-diagnosis. This study therefore showed IGFs are dysregulated both before and after the clinical diagnosis of type 1 diabetes and may be used as novel biomarkers predict type 1 diabetes in the future.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
